➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Johnson and Johnson
Baxter
Medtronic

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

FLOMAX Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Flomax patents expire, and when can generic versions of Flomax launch?

Flomax is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.

Drug patent expirations by year for FLOMAX
Drug Prices for FLOMAX

See drug prices for FLOMAX

Drug Sales Revenue Trends for FLOMAX

See drug sales revenues for FLOMAX

Recent Clinical Trials for FLOMAX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Denver Health and Hospital AuthorityPhase 4
University of Colorado, DenverPhase 4
Kevin J Flynn MDPhase 4

See all FLOMAX clinical trials

Pharmacology for FLOMAX
Paragraph IV (Patent) Challenges for FLOMAX
Tradename Dosage Ingredient NDA Submissiondate
FLOMAX CAPSULE;ORAL tamsulosin hydrochloride 020579 2004-12-20

US Patents and Regulatory Information for FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Try it Free ⤷  Try it Free
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Try it Free ⤷  Try it Free
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Try it Free ⤷  Try it Free
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for FLOMAX

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0034432 96C0048 Belgium ⤷  Try it Free PRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
0034432 SPC/GB96/017: EXPIRE United Kingdom ⤷  Try it Free SPC/GB96/017: EXPIRES: 20060201
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Johnson and Johnson
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.